Charles F. Caley

1.3k total citations
27 papers, 806 citations indexed

About

Charles F. Caley is a scholar working on Psychiatry and Mental health, Pharmacology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Charles F. Caley has authored 27 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Charles F. Caley's work include Schizophrenia research and treatment (14 papers), Electroconvulsive Therapy Studies (7 papers) and Bipolar Disorder and Treatment (6 papers). Charles F. Caley is often cited by papers focused on Schizophrenia research and treatment (14 papers), Electroconvulsive Therapy Studies (7 papers) and Bipolar Disorder and Treatment (6 papers). Charles F. Caley collaborates with scholars based in United States. Charles F. Caley's co-authors include John S. Markowitz, Stanley S. Weber, Joseph H. Friedman, Robert L. Dufresne, B. D. Gaulin, John W. Goethe, Stephen B. Woolley, Theodore R. Holford, Judith C. Kando and Andreas Windemuth and has published in prestigious journals such as American Journal of Psychiatry, Molecular Psychiatry and The Journal of Clinical Psychiatry.

In The Last Decade

Charles F. Caley

26 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles F. Caley United States 14 439 148 144 139 99 27 806
Matthew A. Fuller United States 18 570 1.3× 80 0.5× 131 0.9× 167 1.2× 51 0.5× 52 835
Thomas J. Arndt United States 8 760 1.7× 77 0.5× 71 0.5× 171 1.2× 105 1.1× 8 1.1k
Chun-Hsin Chen Taiwan 24 430 1.0× 110 0.7× 221 1.5× 146 1.1× 101 1.0× 53 1.3k
Pierluigi Scapicchio Italy 9 395 0.9× 83 0.6× 173 1.2× 83 0.6× 47 0.5× 10 652
Robert L. Dufresne United States 14 487 1.1× 73 0.5× 158 1.1× 105 0.8× 61 0.6× 33 720
Yuki Matsuda Japan 19 587 1.3× 88 0.6× 56 0.4× 242 1.7× 141 1.4× 77 1.2k
William E. Falk United States 15 473 1.1× 54 0.4× 99 0.7× 243 1.7× 120 1.2× 31 940
C. Barnas Austria 19 700 1.6× 104 0.7× 67 0.5× 197 1.4× 166 1.7× 61 1.2k
Markus Banger Germany 16 130 0.3× 160 1.1× 116 0.8× 89 0.6× 134 1.4× 43 691
Mary Anne Dellva United States 16 831 1.9× 106 0.7× 295 2.0× 236 1.7× 74 0.7× 44 1.3k

Countries citing papers authored by Charles F. Caley

Since Specialization
Citations

This map shows the geographic impact of Charles F. Caley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles F. Caley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles F. Caley more than expected).

Fields of papers citing papers by Charles F. Caley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles F. Caley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles F. Caley. The network helps show where Charles F. Caley may publish in the future.

Co-authorship network of co-authors of Charles F. Caley

This figure shows the co-authorship network connecting the top 25 collaborators of Charles F. Caley. A scholar is included among the top collaborators of Charles F. Caley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles F. Caley. Charles F. Caley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Suzanne C., Jolene R. Bostwick, Marshall E. Cates, et al.. (2024). Psychiatric learning experiences in PGY1 pharmacy residency training: A 5-year analysis. American Journal of Health-System Pharmacy. 82(11). e507–e513.
2.
Harris, Suzanne C., Jolene R. Bostwick, Amy Werremeyer, et al.. (2021). Addressing the Conflict Between Promoting Wellness, Perpetuating Mental Illness Stigma and Making Psychiatric Pharmacy Education Less Intense. American Journal of Pharmaceutical Education. 85(7). 8354–8354. 4 indexed citations
3.
Giannetti, Vincent J., Charles F. Caley, Khalid M. Kamal, et al.. (2018). Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs. International Journal of Clinical Pharmacy. 40(5). 1096–1105. 33 indexed citations
4.
Caley, Charles F., et al.. (2017). Supporting patients with mental illness: Deconstructing barriers to community pharmacist access. Journal of the American Pharmacists Association. 57(2). 248–255. 33 indexed citations
5.
Caley, Charles F., et al.. (2015). Extrapyramidal Reactions Associated With Serotonergic Antidepressants. Annals of Pharmacotherapy. 49(10). 1136–1152. 50 indexed citations
6.
Caley, Charles F., et al.. (2010). Chronic Leukocytosis Associated with Clozapine Treatment. Clinical Schizophrenia & Related Psychoses. 4(2). 141–144. 10 indexed citations
7.
Caley, Charles F., et al.. (2010). The Role of a Psychiatric Pharmacist in College Health. Journal of American College Health. 58(4). 393–396. 11 indexed citations
8.
Caley, Charles F.. (2009). Bipolar Disorder Patient Care Opportunities: Let's Answer the Call. Annals of Pharmacotherapy. 43(11). 1890–1892. 3 indexed citations
9.
Gugger, James J. & Charles F. Caley. (2007). Clozapine Treatment in a Patient with a Persistently Low Neutrophil Count. Clinical Schizophrenia & Related Psychoses. 1(3). 270–272. 2 indexed citations
10.
Goethe, John W., Bonnie L. Szarek, Charles F. Caley, & Stephen B. Woolley. (2007). Signs and Symptoms Associated With the Metabolic Syndrome in Psychiatric Inpatients Receiving Antipsychotics. The Journal of Clinical Psychiatry. 68(1). 22–28. 15 indexed citations
11.
Ruaño, Gualberto, John W. Goethe, Charles F. Caley, et al.. (2007). Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients. Molecular Psychiatry. 12(5). 474–482. 47 indexed citations
12.
Caley, Charles F., et al.. (2003). Possible Case of Mania Associated with Ma‐Huang. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(3). 380–383. 14 indexed citations
13.
Caley, Charles F. & Judith C. Kando. (2002). SSRI Efficacy—Finding the Right Dose. Journal of Psychiatric Practice. 8(1). 33–40. 11 indexed citations
14.
Caley, Charles F., et al.. (2002). Ziprasidone: The Fifth Atypical Antipsychotic. Annals of Pharmacotherapy. 36. 839–851. 1 indexed citations
15.
Markowitz, John S., et al.. (2001). New onset diabetes and atypical antipsychotics. European Neuropsychopharmacology. 11(1). 25–32. 109 indexed citations
16.
Gaulin, B. D., et al.. (1999). Clozapine-Associated Elevation in Serum Triglycerides. American Journal of Psychiatry. 156(8). 1270–1272. 102 indexed citations
17.
Caley, Charles F.. (1998). Extrapyramidal reactions from concurrent SSRI and atypical antipsychotic use. Irish Journal of Psychological Medicine. 15(2). 76–77. 3 indexed citations
18.
Caley, Charles F.. (1997). Extrapyramidal Reactions and the Selective Serotonin-Reuptake Inhibitors. Annals of Pharmacotherapy. 31(12). 1481–1489. 65 indexed citations
19.
Caley, Charles F.. (1996). The Pharmacotherapy of Human Aggression: A Review. Journal of Pharmacy Practice. 9(2). 133–143. 2 indexed citations
20.
Caley, Charles F. & Stanley S. Weber. (1993). Paroxetine: A Selective Serotonin Reuptake Inhibiting Antidepressant. Annals of Pharmacotherapy. 27(10). 1212–1222. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026